Wealthfront Advisers LLC West Pharmaceutical Services Inc Transaction History

Wealthfront Advisers LLC

  • $38.2 Billion
  • Q2 2025

A detailed history of Wealthfront Advisers LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Wealthfront Advisers LLC holds 2,707 shares of WST stock, worth $777,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,707
Previous 3,571 24.19%
Holding current value
$777,504
Previous $799,000 25.91%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$190.39 - $227.7 $164,496 - $196,732
-864 Reduced 24.19%
2,707 $592,000
Q1 2025

May 02, 2025
SELL
$199.11 - $347.87 $220,812 - $385,787
-1,109 Reduced 23.7%
3,571 $799,000
Q4 2024

Apr 01, 2025
BUY
$285.69 - $344.0 $1.34 Million - $1.61 Million
4,680 New
4,680 $1.53 Million
Q3 2024

Nov 12, 2024
SELL
$277.16 - $333.3 $182,648 - $219,644
-659 Reduced 15.42%
3,615 $1.09 Million
Q2 2024

Aug 14, 2024
SELL
$314.68 - $395.94 $737,924 - $928,479
-2,345 Reduced 35.43%
4,274 $1.41 Million
Q1 2024

Apr 19, 2024
SELL
$338.27 - $413.0 $575,397 - $702,513
-1,701 Reduced 20.44%
6,619 $2.62 Million
Q4 2023

Feb 09, 2024
BUY
$318.29 - $392.21 $1.12 Million - $1.38 Million
3,520 Added 73.33%
8,320 $2.93 Million
Q3 2023

Nov 01, 2023
BUY
$354.9 - $412.41 $20,939 - $24,332
59 Added 1.24%
4,800 $1.8 Million
Q2 2023

Aug 07, 2023
SELL
$334.63 - $382.47 $8,365 - $9,561
-25 Reduced 0.52%
4,741 $1.81 Million
Q1 2023

Apr 28, 2023
BUY
$232.5 - $346.47 $137,872 - $205,456
593 Added 14.21%
4,766 $1.65 Million
Q4 2022

Feb 10, 2023
BUY
$209.34 - $261.61 $167,472 - $209,288
800 Added 23.72%
4,173 $982,000
Q3 2022

Nov 14, 2022
SELL
$246.08 - $343.65 $653,342 - $912,390
-2,655 Reduced 44.04%
3,373 $830,000
Q2 2022

Jul 20, 2022
SELL
$280.61 - $420.45 $211,018 - $316,178
-752 Reduced 11.09%
6,028 $1.82 Million
Q1 2022

May 16, 2022
BUY
$357.49 - $445.92 $361,422 - $450,825
1,011 Added 17.52%
6,780 $2.79 Million
Q4 2021

Jan 21, 2022
SELL
$402.25 - $471.34 $79,243 - $92,853
-197 Reduced 3.3%
5,769 $2.71 Million
Q3 2021

Nov 15, 2021
BUY
$363.01 - $468.47 $27,951 - $36,072
77 Added 1.31%
5,966 $2.53 Million
Q2 2021

Aug 16, 2021
SELL
$284.77 - $363.2 $104,225 - $132,931
-366 Reduced 5.85%
5,889 $2.12 Million
Q1 2021

May 14, 2021
BUY
$257.29 - $307.53 $333,447 - $398,558
1,296 Added 26.13%
6,255 $1.76 Million
Q4 2020

Feb 16, 2021
BUY
$261.16 - $301.66 $243,923 - $281,750
934 Added 23.2%
4,959 $1.41 Million
Q3 2020

Nov 16, 2020
BUY
$224.99 - $288.02 $153,443 - $196,429
682 Added 20.4%
4,025 $1.11 Million
Q2 2020

Aug 14, 2020
BUY
$149.8 - $227.17 $500,781 - $759,429
3,343 New
3,343 $759,000

Others Institutions Holding WST

# of Institutions
842
Shares Held
68.6M
Call Options Held
344K
Put Options Held
144K
View Full List

About WEST PHARMACEUTICAL SERVICES INC

WST Quotes by TradingView
  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $21.3B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Wealthfront Advisers LLC Portfolio

Follow Wealthfront Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email